Cargando…

Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género?

OBJECTIVES: To estimate the use of cardiovascular medicines and its distribution by age and sex. DESIGN: Observational study. SETTING: Region of Murcia. MAIN MEASUREMENTS: Daily doses of cardiovascular drugs prescribed and dispensed in all the pharmacies of the Region per 1,000 inhabitants-day (DHD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez, Diego P., Guillén, José J., Torres, Alberto M., Sánchez, Fernando I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985612/
https://www.ncbi.nlm.nih.gov/pubmed/24210690
http://dx.doi.org/10.1016/j.aprim.2013.09.003
_version_ 1783491841222508544
author Sánchez, Diego P.
Guillén, José J.
Torres, Alberto M.
Sánchez, Fernando I.
author_facet Sánchez, Diego P.
Guillén, José J.
Torres, Alberto M.
Sánchez, Fernando I.
author_sort Sánchez, Diego P.
collection PubMed
description OBJECTIVES: To estimate the use of cardiovascular medicines and its distribution by age and sex. DESIGN: Observational study. SETTING: Region of Murcia. MAIN MEASUREMENTS: Daily doses of cardiovascular drugs prescribed and dispensed in all the pharmacies of the Region per 1,000 inhabitants-day (DHD). A comparison was made of consumption rates (DHD) by age and sex. RESULTS: The probability of receiving antiplatelet drugs increases with age, with the proportion of men being higher. The use of beta-blockers and angiotensin II increases with age up to 79 years, with an increased consumption in men up to 65 years. The probability of receiving treatment with calcium channel blockers, ACE inhibitors, or statins, linearly increases with age, and the proportion of men under treatment exceeds that of women in the early ages, tending to equalize beyond 80 years. CONCLUSIONS: This study shows that the cardiovascular disease prevention focuses on people aged 40 to 74 years. Access by women to cardiovascular therapy occurs with a delay of 3-5 years, depending on the treatment subgroup. Changes should be promoted to encourage rational and equitable access and use of the drugs.
format Online
Article
Text
id pubmed-6985612
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69856122020-01-30 Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género? Sánchez, Diego P. Guillén, José J. Torres, Alberto M. Sánchez, Fernando I. Aten Primaria Originales OBJECTIVES: To estimate the use of cardiovascular medicines and its distribution by age and sex. DESIGN: Observational study. SETTING: Region of Murcia. MAIN MEASUREMENTS: Daily doses of cardiovascular drugs prescribed and dispensed in all the pharmacies of the Region per 1,000 inhabitants-day (DHD). A comparison was made of consumption rates (DHD) by age and sex. RESULTS: The probability of receiving antiplatelet drugs increases with age, with the proportion of men being higher. The use of beta-blockers and angiotensin II increases with age up to 79 years, with an increased consumption in men up to 65 years. The probability of receiving treatment with calcium channel blockers, ACE inhibitors, or statins, linearly increases with age, and the proportion of men under treatment exceeds that of women in the early ages, tending to equalize beyond 80 years. CONCLUSIONS: This study shows that the cardiovascular disease prevention focuses on people aged 40 to 74 years. Access by women to cardiovascular therapy occurs with a delay of 3-5 years, depending on the treatment subgroup. Changes should be promoted to encourage rational and equitable access and use of the drugs. Elsevier 2014-03 2013-11-06 /pmc/articles/PMC6985612/ /pubmed/24210690 http://dx.doi.org/10.1016/j.aprim.2013.09.003 Text en © 2013 Elsevier España, S.L. Todos los derechos reservados. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Originales
Sánchez, Diego P.
Guillén, José J.
Torres, Alberto M.
Sánchez, Fernando I.
Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género?
title Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género?
title_full Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género?
title_fullStr Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género?
title_full_unstemmed Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género?
title_short Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género?
title_sort análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la región de murcia: ¿existen diferencias de género?
topic Originales
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985612/
https://www.ncbi.nlm.nih.gov/pubmed/24210690
http://dx.doi.org/10.1016/j.aprim.2013.09.003
work_keys_str_mv AT sanchezdiegop analisisdeladispensaciondemedicamentosparaelcontroldelosprincipalesfactoresderiesgocardiovascularenlaregiondemurciaexistendiferenciasdegenero
AT guillenjosej analisisdeladispensaciondemedicamentosparaelcontroldelosprincipalesfactoresderiesgocardiovascularenlaregiondemurciaexistendiferenciasdegenero
AT torresalbertom analisisdeladispensaciondemedicamentosparaelcontroldelosprincipalesfactoresderiesgocardiovascularenlaregiondemurciaexistendiferenciasdegenero
AT sanchezfernandoi analisisdeladispensaciondemedicamentosparaelcontroldelosprincipalesfactoresderiesgocardiovascularenlaregiondemurciaexistendiferenciasdegenero